266 related articles for article (PubMed ID: 9144445)
1. Pharmacologic modulation of reduced glutathione circadian rhythms with buthionine sulfoximine: relationship with cisplatin toxicity in mice.
Li XM; Metzger G; Filipski E; Boughattas N; Lemaigre G; Hecquet B; Filipski J; Levi F
Toxicol Appl Pharmacol; 1997 Apr; 143(2):281-90. PubMed ID: 9144445
[TBL] [Abstract][Full Text] [Related]
2. Modulation of cisplatin chronotoxicity related to reduced glutathione in mice.
Boughattas NA; Li XM; Filipski J; Lemaigre G; Filipski E; Bouzouita K; Belhadj O; Lévi F
Hum Exp Toxicol; 1996 Jul; 15(7):563-72. PubMed ID: 8818709
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modulation of cisplatin toxicity rhythms with buthionine sulfoximine in mice bearing pancreatic adenocarcinoma (PO3).
Li XM; Filipski E; Lévi F
Chronobiol Int; 1998 Jul; 15(4):323-35. PubMed ID: 9706410
[TBL] [Abstract][Full Text] [Related]
4. Stable circadian mechanisms of toxicity of two platinum analogs (cisplatin and carboplatin) despite repeated dosages in mice.
Boughattas NA; Lévi F; Fournier C; Hecquet B; Lemaigre G; Roulon A; Mathé G; Reinberg A
J Pharmacol Exp Ther; 1990 Nov; 255(2):672-9. PubMed ID: 2243347
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of cyanohydroxybutene on glutathione synthesis in liver and pancreas of male rats.
Davis MA; Wallig MA; Eaton D; Borroz KI; Jeffery EH
Toxicol Appl Pharmacol; 1993 Dec; 123(2):257-64. PubMed ID: 7902618
[TBL] [Abstract][Full Text] [Related]
6. Depletion of glutathione in the kidney and the renal disposition of administered inorganic mercury.
Zalups RK; Lash LH
Drug Metab Dispos; 1997 Apr; 25(4):516-23. PubMed ID: 9107552
[TBL] [Abstract][Full Text] [Related]
7. Sensitive enzymatic cycling assay for glutathione: measurements of glutathione content and its modulation by buthionine sulfoximine in vivo and in vitro in human colon cancer.
Berger SJ; Gosky D; Zborowska E; Willson JK; Berger NA
Cancer Res; 1994 Aug; 54(15):4077-83. PubMed ID: 8033140
[TBL] [Abstract][Full Text] [Related]
8. Glutathione depletion by buthionine sulfoximine induces oxidative damage to DNA in organs of rabbits in vivo.
Gokce G; Ozsarlak-Sozer G; Oktay G; Kirkali G; Jaruga P; Dizdaroglu M; Kerry Z
Biochemistry; 2009 Jun; 48(22):4980-7. PubMed ID: 19374446
[TBL] [Abstract][Full Text] [Related]
9. Evidence for embryonic peroxidase-catalyzed bioactivation and glutathione-dependent cytoprotection in phenytoin teratogenicity: modulation by eicosatetraynoic acid and buthionine sulfoximine in murine embryo culture.
Miranda AF; Wiley MJ; Wells PG
Toxicol Appl Pharmacol; 1994 Feb; 124(2):230-41. PubMed ID: 8122268
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of cisplatin toxicity by buthionine sulfoximine, a glutathione-depleting agent, in mice.
Ishikawa M; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Jan; 67(1):131-41. PubMed ID: 2326543
[TBL] [Abstract][Full Text] [Related]
11. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
Ono K; Shrieve DC
J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
[TBL] [Abstract][Full Text] [Related]
12. Glutathione depletion in rested and exercised mice: biochemical consequence and adaptation.
Leeuwenburgh C; Ji LL
Arch Biochem Biophys; 1995 Feb; 316(2):941-9. PubMed ID: 7864653
[TBL] [Abstract][Full Text] [Related]
13. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
[TBL] [Abstract][Full Text] [Related]
14. Role of glutathione for cisplatin nephrotoxicity in young and adult rats.
Appenroth D; Winnefeld K
Ren Fail; 1993; 15(2):135-9. PubMed ID: 8469780
[TBL] [Abstract][Full Text] [Related]
15. Effects of acute glutathione depletion induced by L-buthionine-(S,R)-sulfoximine on rat liver glucose-6-phosphatase activity.
Santori G; Domenicotti C; Bellocchio A; Pronzato MA; Marinari UM; Poli G; Cottalasso D
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):165-78. PubMed ID: 9467825
[TBL] [Abstract][Full Text] [Related]
16. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
Reliene R; Schiestl RH
Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
[TBL] [Abstract][Full Text] [Related]
17. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis.
Lopez SG; Luderer U
Free Radic Biol Med; 2004 Jun; 36(11):1366-77. PubMed ID: 15135172
[TBL] [Abstract][Full Text] [Related]
18. Increased lipid peroxidation in the liver and kidney and their mitochondrial fractions following buthionine sulfoximine induced glutathione depletion in guinea pigs.
Seçkin S; Doğru-Abbasoğlu S; Başaran-Küçükgergin C; Yavu E; Cevikbaş U; Aykaç-Toker G; Uysal M
Res Commun Mol Pathol Pharmacol; 2001; 109(5-6):299-308. PubMed ID: 12889513
[TBL] [Abstract][Full Text] [Related]
19. Induction of colon tumorigenesis by glutathione depletion in p53-knock-out mice.
Richie JP; Komninou D; Albino AP
Int J Oncol; 2007 Jun; 30(6):1539-43. PubMed ID: 17487376
[TBL] [Abstract][Full Text] [Related]
20. Nephrotoxicity of thioformamide, a proximate toxicant of nephrotoxic thiazoles, in mice depleted of glutathione.
Mizutani T; Suzuki K; Murakami M; Yoshida K; Nakanishi K
Res Commun Mol Pathol Pharmacol; 1996 Oct; 94(1):89-101. PubMed ID: 8948017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
